"Recombinant Hepatitis B Vaccination of Neonates and Infants: Emerging Safety Data from the Vaccine Adverse Event Reporting System."

According to the authors' abstract of an article published in Pediatric Infectious Disease Journal, "Objectives: To evaluate the postmarketing safety of recombinant hepatitis B (HB) vaccine given to neonates and infants in the US, Methods: US reports associated with HE vaccination and received between January 1, 1991, and May 31, 1995, by the national Vaccine Adverse Events Reporting System (VAERS) were reviewed as a case series, Results: During 1991 through 1994, 12 520 (32%) VAERS reports were received for events temporally associated with administration of HB vaccine, of which 14% were received for neonates and infants. More reports described serious...

Want to see the full article?

• Purchase this article for only $3.00